Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|August 25, 2022
Ceramide Metabolism in Cardiovascular Disease: A Network With High Therapeutic PotentialAndreas Zietzer, Philip Düsing, Laurine Reese, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 22, 2021
Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approachesPhilip Düsing, Andreas Zietzer, Philip Roger Goody, et al.
BMC Cardiovascular Disorders|September 12, 2023
Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitusPhilip Düsing, Nadine N Heinrich, Baravan Al-Kassou, et al.
Acta Physiologica (Oxford, England)|March 28, 2024
Loss of ceramide synthase 5 inhibits the development of experimentally induced aortic valve stenosisLaurine Reese, Sven Thomas Niepmann, Philip Düsing, et al.
Cellular and Molecular Life Sciences : CMLS|December 24, 2021
Activation of neutral sphingomyelinase 2 through hyperglycemia contributes to endothelial apoptosis via vesicle-bound intercellular transfer of ceramidesAndreas Zietzer, Alina Lisann Jahnel, Marko Bulic, et al.
Frontiers in Molecular Biosciences|November 22, 2021
NcRNAs in Vascular and Valvular Intercellular CommunicationBenedikt Bartsch, Philip Roger Goody, Mohammed Rabiul Hosen, et al.
Antioxidants & Redox Signaling|May 16, 2020
MicroRNAs As Master Regulators of Atherosclerosis: From Pathogenesis to Novel Therapeutic OptionsMohammed Rabiul Hosen, Philip Roger Goody, Andreas Zietzer, et al.
Cardiovascular Research|June 26, 2025
The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosisPhilip Düsing, Isabel Göbel, Ansgar Ackerschott, et al.
Journal of Molecular and Cellular Cardiology|September 19, 2017
Endothelial microparticle-promoted inhibition of vascular remodeling is abrogated under hyperglycaemic conditionsFelix Jansen, Andreas Zietzer, Tobias Stumpf, et al.
Pageof 8